Type:Proposed Rule
Citation:89 FR 106376
Reading Time:about 37 minutes
The Drug Enforcement Administration (DEA) is proposing to place the substance 4-chloromethcathinone (4-CMC) in schedule I of the Controlled Substances Act. This move aims to impose strict regulations similar to other highly controlled drugs, as 4-CMC is known to have a high potential for abuse and no accepted medical use in the U.S. The decision also helps the United States comply with international agreements on psychotropic substances. Public comments on this proposal are accepted until January 29, 2025.
Simple Explanation
The DEA wants to treat a drug called 4-CMC like other dangerous drugs because it's risky and doesn't have a medical purpose. They also want to follow international rules about such drugs.